High risk of fracture Osteoporosis
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB05084 | Abaloparatide | A parathyroid hormone-related protein (PTHrP) analog used for the treatment of osteoporosis in postmenopausal women with a high risk of fracture. |
| DB06643 | Denosumab | A RANK ligand (RANKL) inhibitor used for the management of osteoporosis in patients at high risk for bone fractures. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB05084 | Abaloparatide | Parathyroid hormone/parathyroid hormone-related peptide receptor | target |
| DB06643 | Denosumab | Tumor necrosis factor ligand superfamily member 11 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|